To gain further insight into the mechanisms by which RAS regulates SLC3A2 and MTOR associations, we performed GO pathway analysis on BioID2-SLC3A2 interactors that were reduced by at least 0.5 log2fc following RAS knockdown in any of the four MM lines tested. Here, SLC3A2 is linked to Miyoshi myopathy.